| 1A1M | B: | MHC CLASS I MOLECULE B*5301 COMPLEXED WITH PEPTIDE TPYDINQML FROM GAG PROTEIN OF HIV2 |
| 1A1N | B: | MHC CLASS I MOLECULE B*3501 COMPLEXED WITH PEPTIDE VPLRPMTY FROM THE NEF PROTEIN (75-82) OF HIV1 |
| 1A1O | B: | MHC CLASS I MOLECULE B*5301 COMPLEXED WITH PEPTIDE LS6 (KPIVQYDNF) FROM THE MALARIA PARASITE P. FALCIPARUM |
| 1A6Z | B:; D: | HFE (HUMAN) HEMOCHROMATOSIS PROTEIN |
| 1A9B | B:; E: | DECAMER-LIKE CONFORMATION OF A NANO-PEPTIDE BOUND TO HLA-B3501 DUE TO NONSTANDARD POSITIONING OF THE C-TERMINUS |
| 1A9E | B: | DECAMER-LIKE CONFORMATION OF A NANO-PEPTIDE BOUND TO HLA-B3501 DUE TO NONSTANDARD POSITIONING OF THE C-TERMINUS |
| 1AGB | B: | ANTAGONIST HIV-1 GAG PEPTIDES INDUCE STRUCTURAL CHANGES IN HLA B8-HIV-1 GAG PEPTIDE (GGRKKYKL-3R MUTATION) |
| 1AGC | B: | ANTAGONIST HIV-1 GAG PEPTIDES INDUCE STRUCTURAL CHANGES IN HLA B8-HIV-1 GAG PEPTIDE (GGKKKYQL-7Q MUTATION) |
| 1AGD | B: | ANTAGONIST HIV-1 GAG PEPTIDES INDUCE STRUCTURAL CHANGES IN HLA B8-HIV-1 GAG PEPTIDE (GGKKKYKL-INDEX PEPTIDE) |
| 1AGE | B: | ANTAGONIST HIV-1 GAG PEPTIDES INDUCE STRUCTURAL CHANGES IN HLA B8-HIV-1 GAG PEPTIDE (GGKKKYRL-7R MUTATION) |
| 1AGF | B: | ANTAGONIST HIV-1 GAG PEPTIDES INDUCE STRUCTURAL CHANGES IN HLA B8-HIV-1 GAG PEPTIDE (GGKKRYKL-5R MUTATION) |
| 1AKJ | B: | COMPLEX OF THE HUMAN MHC CLASS I GLYCOPROTEIN HLA-A2 AND THE T CELL CORECEPTOR CD8 |
| 1AO7 | B: | COMPLEX BETWEEN HUMAN T-CELL RECEPTOR, VIRAL PEPTIDE (TAX), AND HLA-A 0201 |
| 1B0G | B:; E: | CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA-A2.1)/BETA 2-MICROGLOBULIN/PEPTIDE P1049 COMPLEX |
| 1B0R | B: | CRYSTAL STRUCTURE OF HLA-A*0201 COMPLEXED WITH A PEPTIDE WITH THE CARBOXYL-TERMINAL GROUP SUBSTITUTED BY A METHYL GROUP |
| 1BD2 | B: | COMPLEX BETWEEN HUMAN T-CELL RECEPTOR B7, VIRAL PEPTIDE (TAX) AND MHC CLASS I MOLECULE HLA-A 0201 |
| 1C16 | B:; D:; F:; H: | CRYSTAL STRUCTURE ANALYSIS OF THE GAMMA/DELTA T CELL LIGAND T22 |
| 1CE6 | B: | MHC CLASS I H-2DB COMPLEXED WITH A SENDAI VIRUS NUCLEOPROTEIN PEPTIDE |
| 1CG9 | B: | COMPLEX RECOGNITION OF THE SUPERTYPIC BW6-DETERMINANT ON HLA-B AND-C MOLECULES BY THE MONOCLONAL ANTIBODY SFR8-B6 |
| 1DE4 | B:; E:; H: | HEMOCHROMATOSIS PROTEIN HFE COMPLEXED WITH TRANSFERRIN RECEPTOR |
| 1DUY | B:; E: | CRYSTAL STRUCTURE OF HLA-A*0201/OCTAMERIC TAX PEPTIDE COMPLEX |
| 1DUZ | B:; E: | HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA-A 0201) IN COMPLEX WITH A NONAMERIC PEPTIDE FROM HTLV-1 TAX PROTEIN |
| 1E27 | B: | NONSTANDARD PEPTIDE BINDING OF HLA-B*5101 COMPLEXED WITH HIV IMMUNODOMINANT EPITOPE KM1(LPPVVAKEI) |
| 1E28 | B: | NONSTANDARD PEPTIDE BINDING OF HLA-B*5101 COMPLEXED WITH HIV IMMUNODOMINANT EPITOPE KM2(TAFTIPSI) |
| 1EEY | B:; E: | CRYSTAL STRUCTURE DETERMINATION OF HLA A2 COMPLEXED TO PEPTIDE GP2 WITH THE SUBSTITUTION (I2L/V5L/L9V) |
| 1EEZ | B:; E: | CRYSTAL STRUCTURE DETERMINATION OF HLA-A2.1 COMPLEXED TO GP2 PEPTIDE VARIANT(I2L/V5L) |
| 1EFX | B: | STRUCTURE OF A COMPLEX BETWEEN THE HUMAN NATURAL KILLER CELL RECEPTOR KIR2DL2 AND A CLASS I MHC LIGAND HLA-CW3 |
| 1EXU | B: | CRYSTAL STRUCTURE OF THE HUMAN MHC-RELATED FC RECEPTOR |
| 1GZP | B: | CD1B IN COMPLEX WITH GM2 GANGLIOSIDE |
| 1GZQ | B: | CD1B IN COMPLEX WITH PHOPHATIDYLINOSITOL |
| 1HHG | B:; E: | THE ANTIGENIC IDENTITY OF PEPTIDE(SLASH)MHC COMPLEXES: A COMPARISON OF THE CONFORMATION OF FIVE PEPTIDES PRESENTED BY HLA-A2 |
| 1HHH | B: | THE ANTIGENIC IDENTITY OF PEPTIDE(SLASH)MHC COMPLEXES: A COMPARISON OF THE CONFORMATION OF FIVE PEPTIDES PRESENTED BY HLA-A2 |
| 1HHI | B:; E: | THE ANTIGENIC IDENTITY OF PEPTIDE(SLASH)MHC COMPLEXES: A COMPARISON OF THE CONFORMATION OF FIVE PEPTIDES PRESENTED BY HLA-A2 |
| 1HHJ | B:; E: | THE ANTIGENIC IDENTITY OF PEPTIDE(SLASH)MHC COMPLEXES: A COMPARISON OF THE CONFORMATION OF FIVE PEPTIDES PRESENTED BY HLA-A2 |
| 1HHK | B:; E: | THE ANTIGENIC IDENTITY OF PEPTIDE(SLASH)MHC COMPLEXES: A COMPARISON OF THE CONFORMATION OF FIVE PEPTIDES PRESENTED BY HLA-A2 |
| 1HLA | M: | STRUCTURE OF THE HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN, HLA-A2 |
| 1HSA | B:; E: | THE THREE-DIMENSIONAL STRUCTURE OF HLA-B27 AT 2.1 ANGSTROMS RESOLUTION SUGGESTS A GENERAL MECHANISM FOR TIGHT PEPTIDE BINDING TO MHC |
| 1HSB | B: | DIFFERENT LENGTH PEPTIDES BIND TO HLA-AW68 SIMILARLY AT THEIR ENDS BUT BULGE OUT IN THE MIDDLE |
| 1I1F | B:; E: | CRYSTAL STRUCTURE OF HUMAN CLASS I MHC (HLA-A2.1) COMPLEXED WITH BETA 2-MICROGLOBULIN AND HIV-RT VARIANT PEPTIDE I1Y |
| 1I1Y | B:; E: | CRYSTAL STRUCTURE OF HUMAN CLASS I MHC (HLA-A2.1) COMPLEXED WITH BETA 2-MICROGLOBULIN AND HIV-RT VARIANT PEPTIDE I1Y |
| 1I4F | B: | CRYSTAL STRUCTURE OF HLA-A*0201/MAGE-A4-PEPTIDE COMPLEX |
| 1I7R | B:; E: | CRYSTAL STRUCTURE OF CLASS I MHC A2 IN COMPLEX WITH PEPTIDE P1058 |
| 1I7T | B:; E: | CRYSTAL STRUCTURE OF CLASS I MHC A2 IN COMPLEX WITH PEPTIDE P1049-5V |
| 1I7U | B:; E: | CRYSTAL STRUCTURE OF CLASS I MHC A2 IN COMPLEX WITH PEPTIDE P1049-6V |
| 1IM3 | B:; F:; J:; N: | CRYSTAL STRUCTURE OF THE HUMAN CYTOMEGALOVIRUS PROTEIN US2 BOUND TO THE MHC CLASS I MOLECULE HLA-A2/TAX |
| 1IM9 | B:; F: | CRYSTAL STRUCTURE OF THE HUMAN NATURAL KILLER CELL INHIBITORY RECEPTOR KIR2DL1 BOUND TO ITS MHC LIGAND HLA-CW4 |
| 1JF1 | B: | CRYSTAL STRUCTURE OF HLA-A2*0201 IN COMPLEX WITH A DECAMERIC ALTERED PEPTIDE LIGAND FROM THE MART-1/MELAN-A |
| 1JGD | B: | HLA-B*2709 BOUND TO DECA-PEPTIDE S10R |
| 1JGE | B: | HLA-B*2705 BOUND TO NONA-PEPTIDE M9 |
| 1JHT | B: | CRYSTAL STRUCTURE OF HLA-A2*0201 IN COMPLEX WITH A NONAMERIC ALTERED PEPTIDE LIGAND (ALGIGILTV) FROM THE MART-1/MELAN-A. |
| 1JNJ | A: | NMR SOLUTION STRUCTURE OF THE HUMAN BETA2-MICROGLOBULIN |
| 1K5N | B: | HLA-B*2709 BOUND TO NONA-PEPTIDE M9 |
| 1KPR | B:; D: | THE HUMAN NON-CLASSICAL MAJOR HISTOCOMPATIBILITY COMPLEX MOLECULE HLA-E |
| 1KTL | B:; D: | THE HUMAN NON-CLASSICAL MAJOR HISTOCOMPATIBILITY COMPLEX MOLECULE HLA-E |
| 1LDS | A: | CRYSTAL STRUCTURE OF MONOMERIC HUMAN BETA-2-MICROGLOBULIN |
| 1LP9 | B:; I: | XENOREACTIVE COMPLEX AHIII 12.2 TCR BOUND TO P1049/HLA-A2.1 |
| 1M05 | B:; D: | HLA B8 IN COMPLEX WITH AN EPSTEIN BARR VIRUS DETERMINANT |
| 1M6O | B: | CRYSTAL STRUCTURE OF HLA B*4402 IN COMPLEX WITH HLA DPA*0201 PEPTIDE |
| 1MHE | B:; D: | THE HUMAN NON-CLASSICAL MAJOR HISTOCOMPATIBILITY COMPLEX MOLECULE HLA-E |
| 1MI5 | B: | THE CRYSTAL STRUCTURE OF LC13 TCR IN COMPLEX WITH HLAB8-EBV PEPTIDE COMPLEX |
| 1N2R | B: | A NATURAL SELECTED DIMORPHISM IN HLA B*44 ALTERS SELF, PEPTIDE REPORTOIRE AND T CELL RECOGNITION. |
| 1OF2 | B: | CRYSTAL STRUCTURE OF HLA-B*2709 COMPLEXED WITH THE VASOACTIVE INTESTINAL PEPTIDE TYPE 1 RECEPTOR (VIPR) PEPTIDE (RESIDUES 400-408) |
| 1OGA | B: | A STRUCTURAL BASIS FOR IMMUNODOMINANT HUMAN T-CELL RECEPTOR RECOGNITION. |
| 1OGT | B: | CRYSTAL STRUCTURE OF HLA-B*2705 COMPLEXED WITH THE VASOACTIVE INTESTINAL PEPTIDE TYPE 1 RECEPTOR (VIPR) PEPTIDE (RESIDUES 400-408) |
| 1ONQ | B:; D: | CRYSTAL STRUCTURE OF CD1A IN COMPLEX WITH A SULFATIDE |
| 1P7Q | B: | CRYSTAL STRUCTURE OF HLA-A2 BOUND TO LIR-1, A HOST AND VIRAL MHC RECEPTOR |
| 1PY4 | A:; B:; C:; D: | BETA2 MICROGLOBULIN MUTANT H31Y DISPLAYS HINTS FOR AMYLOID FORMATIONS |
| 1Q94 | B:; E: | STRUCTURES OF HLA-A*1101 IN COMPLEX WITH IMMUNODOMINANT NONAMER AND DECAMER HIV-1 EPITOPES CLEARLY REVEAL THE PRESENCE OF A MIDDLE ANCHOR RESIDUE |
| 1QEW | B: | HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA-A 0201) COMPLEX WITH A NONAMERIC PEPTIDE FROM MELANOMA-ASSOCIATED ANTIGEN 3 (RESIDUES 271-279) |
| 1QLF | B: | MHC CLASS I H-2DB COMPLEXED WITH GLYCOPEPTIDE K3G |
| 1QQD | B: | CRYSTAL STRUCTURE OF HLA-CW4, A LIGAND FOR THE KIR2D NATURAL KILLER CELL INHIBITORY RECEPTOR |
| 1QR1 | B:; E: | POOR BINDING OF A HER-2/NEU EPITOPE (GP2) TO HLA-A2.1 IS DUE TO A LACK OF INTERACTIONS IN THE CENTER OF THE PEPTIDE |
| 1QRN | B: | CRYSTAL STRUCTURE OF HUMAN A6 TCR COMPLEXED WITH HLA-A2 BOUND TO ALTERED HTLV-1 TAX PEPTIDE P6A |
| 1QSE | B: | STRUCTURE OF HUMAN A6-TCR BOUND TO HLA-A2 COMPLEXED WITH ALTERED HTLV-1 TAX PEPTIDE V7R |
| 1QSF | B: | STRUCTURE OF A6-TCR BOUND TO HLA-A2 COMPLEXED WITH ALTERED HTLV-1 TAX PEPTIDE Y8A |
| 1QVO | B:; E: | STRUCTURES OF HLA-A*1101 IN COMPLEX WITH IMMUNODOMINANT NONAMER AND DECAMER HIV-1 EPITOPES CLEARLY REVEAL THE PRESENCE OF A MIDDLE ANCHOR RESIDUE |
| 1R3H | B:; D:; F:; H: | CRYSTAL STRUCTURE OF T10 |
| 1S8D | B: | STRUCTURAL BASIS FOR DEGENERATE RECOGNITION OF HIV PEPTIDE VARIANTS BY CYTOTOXIC LYMPHOCYTE, VARIANT SL9-3A |
| 1S9W | B: | CRYSTAL STRUCTURE ANALYSIS OF NY-ESO-1 EPITOPE, SLLMWITQC, IN COMPLEX WITH HLA-A2 |
| 1S9X | B: | CRYSTAL STRUCTURE ANALYSIS OF NY-ESO-1 EPITOPE ANALOGUE, SLLMWITQA, IN COMPLEX WITH HLA-A2 |
| 1S9Y | B: | CRYSTAL STRUCTURE ANALYSIS OF NY-ESO-1 EPITOPE ANALOGUE, SLLMWITQS, IN COMPLEX WITH HLA-A2 |
| 1SYS | B: | CRYSTAL STRUCTURE OF HLA, B*4403, AND PEPTIDE EEPTVIKKY |
| 1SYV | B: | HLA-B*4405 COMPLEXED TO THE DOMINANT SELF LIGAND EEFGRAYGF |
| 1T1W | B: | STRUCTURAL BASIS FOR DEGENERATE RECOGNITION OF HIV PEPTIDE VARIANTS BY CYTOTOXIC LYMPHOCYTE, VARIANT SL9-3F6I8V |
| 1T1X | B: | STRUCTURAL BASIS FOR DEGENERATE RECOGNITION OF HIV PEPTIDE VARIANTS BY CYTOTOXIC LYMPHOCYTE, VARIANT SL9-4L |
| 1T1Y | B: | STRUCTURAL BASIS FOR DEGENERATE RECOGNITION OF HIV PEPTIDE VARIANTS BY CYTOTOXIC LYMPHOCYTE, VARIANT SL9-5V |
| 1T1Z | B: | STRUCTURAL BASIS FOR DEGENERATE RECOGNITION OF HIV PEPTIDE VARIANTS BY CYTOTOXIC LYMPHOCYTE, VARIANT SL9-6A |
| 1T20 | B: | STRUCTURAL BASIS FOR DEGENERATE RECOGNITION OF HIV PEPTIDE VARIANTS BY CYTOTOXIC LYMPHOCYTE, VARIANT SL9-6I |
| 1T21 | B: | STRUCTURAL BASIS FOR DEGENERATE RECOGNITION OF HIV PEPTIDE VARIANTS BY CYTOTOXIC LYMPHOCYTE, VARIANT SL9, MONOCLINIC CRYSTAL |
| 1T22 | B: | STRUCTURAL BASIS FOR DEGENERATE RECOGNITION OF HIV PEPTIDE VARIANTS BY CYTOTOXIC LYMPHOCYTE, VARIANT SL9, ORTHORHOMBIC CRYSTAL |
| 1TMC | B: | THE THREE-DIMENSIONAL STRUCTURE OF A CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX MOLECULE MISSING THE ALPHA3 DOMAIN OF THE HEAVY CHAIN |
| 1TVB | B:; E: | CRYSTAL STRUCTURE OF MELANOMA ANTIGEN GP100(209-217) BOUND TO HUMAN CLASS I MHC HLA-A2 |
| 1TVH | B:; E: | CRYSTAL STRUCTURE OF MODIFIED MELANOMA ANTIGEN GP100(209-T2M) BOUND TO HUMAN CLASS I MHC HLA-A2 |
| 1UQS | B: | THE CRYSTAL STRUCTURE OF HUMAN CD1B WITH A BOUND BACTERIAL GLYCOLIPID |
| 1UXS | B: | CRYSTAL STRUCTURE OF HLA-B*2705 COMPLEXED WITH THE LATENT MEMBRANE PROTEIN 2 PEPTIDE (LMP2)OF EPSTEIN-BARR VIRUS |
| 1UXW | B: | CRYSTAL STRUCTURE OF HLA-B*2709 COMPLEXED WITH THE LATENT MEMBRANE PROTEIN 2 PEPTIDE (LMP2) OF EPSTEIN-BARR VIRUS |
| 1VGK | B: | THE CRYSTAL STRUCTURE OF CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX, H-2KD AT 2.0 A RESOLUTION |
| 1W0V | B: | CRYSTAL STRUCTURE OF HLA-B*2705 COMPLEXED WITH THE SELF-PEPTIDE TIS FROM EGF-RESPONSE FACTOR 1 |
| 1W0W | B: | CRYSTAL STRUCTURE OF HLA-B*2709 COMPLEXED WITH THE SELF-PEPTIDE TIS FROM EGF-RESPONSE FACTOR 1 |
| 1W72 | B:; E: | CRYSTAL STRUCTURE OF HLA-A1:MAGE-A1 IN COMPLEX WITH FAB-HYB3 |
| 1X7Q | B: | CRYSTAL STRUCTURE OF HLA-A*1101 WITH SARS NUCLEOCAPSID PEPTIDE |
| 1XH3 | B: | CONFORMATIONAL RESTRAINTS AND FLEXIBILITY OF 14-MERIC PEPTIDES IN COMPLEX WITH HLA-B*3501 |
| 1XR8 | B: | CRYSTAL STRUCTURES OF HLA-B*1501 IN COMPLEX WITH PEPTIDES FROM HUMAN UBCH6 AND EPSTEIN-BARR VIRUS EBNA-3 |
| 1XR9 | B: | CRYSTAL STRUCTURES OF HLA-B*1501 IN COMPLEX WITH PEPTIDES FROM HUMAN UBCH6 AND EPSTEIN-BARR VIRUS EBNA-3 |
| 1XZ0 | B:; D: | CRYSTAL STRUCTURE OF CD1A IN COMPLEX WITH A SYNTHETIC MYCOBACTIN LIPOPEPTIDE |
| 1YDP | B: | 1.9A CRYSTAL STRUCTURE OF HLA-G |
| 1YPZ | B:1-99; D:1-99 | IMMUNE RECEPTOR |
| 1ZHK | B: | CRYSTAL STRUCTURE OF HLA-B*3501 PRESENTING 13-MER EBV ANTIGEN LPEPLPQGQLTAY |
| 1ZHL | B: | CRYSTAL STRUCTURE OF HLA-B*3508 PRESENTING 13-MER EBV ANTIGEN LPEPLPQGQLTAY |
| 1ZS8 | B:; D:; F:; H:; J: | CRYSTAL STRUCTURE OF THE MURINE MHC CLASS IB MOLECULE M10.5 |
| 1ZSD | B: | CRYSTAL STRUCTURE OF HLA-B*3501 PRESENTING AN 11-MER EBV ANTIGEN EPLPQGQLTAY |
| 1ZT4 | B:; D: | THE CRYSTAL STRUCTURE OF HUMAN CD1D WITH AND WITHOUT ALPHA-GALACTOSYLCERAMIDE |
| 1ZVS | B:; E: | CRYSTAL STRUCTURE OF THE FIRST CLASS MHC MAMU AND TAT-TL8 COMPLEX |
| 2A83 | B: | CRYSTAL STRUCTURE OF HLA-B*2705 COMPLEXED WITH THE GLUCAGON RECEPTOR (GR) PEPTIDE (RESIDUES 412-420) |
| 2AK4 | B:; G:; L:; R: | CRYSTAL STRUCTURE OF SB27 TCR IN COMPLEX WITH HLA-B*3508-13MER PEPTIDE |
| 2AV1 | B:; E: | CRYSTAL STRUCTURE OF HTLV-1 TAX PEPTIDE BOUND TO HUMAN CLASS I MHC HLA-A2 WITH THE E63Q AND K66A MUTATIONS IN THE HEAVY CHAIN. |
| 2AV7 | B:; E: | CRYSTAL STRUCTURE OF HTLV-1 TAX PEPTIDE BOUND TO HUMAN CLASS I MHC HLA-A2 WITH THE K66A MUTATION IN THE HEAVY CHAIN. |
| 2AXF | B: | THE IMMUNOGENICITY OF A VIRAL CYTOTOXIC T CELL EPITOPE IS CONTROLLED BY ITS MHC-BOUND CONFORMATION |
| 2AXG | B: | THE IMMUNOGENICITY OF A VIRAL CYTOTOXIC T CELL EPITOPE IS CONTROLLED BY ITS MHC-BOUND CONFORMATION |
| 2BCK | B:; E: | CRYSTAL STRUCTURE OF HLA-A*2402 COMPLEXED WITH A TELOMERASE PEPTIDE |
| 2BNQ | B: | STRUCTURAL AND KINETIC BASIS FOR HEIGHTENED IMMUNOGENICITY OF T CELL VACCINES |
| 2BNR | B: | STRUCTURAL AND KINETIC BASIS FOR HEIGHTENED IMMUNOGENICITY OF T CELL VACCINES |
| 2BSR | B: | CRYSTAL STRUCTURES AND KIR3DL1 RECOGNITION OF THREE IMMUNODOMINANT VIRAL PEPTIDES COMPLEXED TO HLA-B2705 |
| 2BSS | B: | CRYSTAL STRUCTURES AND KIR3DL1 RECOGNITION OF THREE IMMUNODOMINANT VIRAL PEPTIDES COMPLEXED TO HLA-B2705 |
| 2BST | B: | CRYSTAL STRUCTURES AND KIR3DL1 RECOGNITION OF THREE IMMUNODOMINANT VIRAL PEPTIDES COMPLEXED TO HLA-B2705 |
| 2BVO | B: | STRUCTURES OF THREE HIV-1 HLA-B5703-PEPTIDE COMPLEXES AND IDENTIFICATION OF RELATED HLAS POTENTIALLY ASSOCIATED WITH LONG-TERM NON-PROGRESSION |
| 2BVP | B: | STRUCTURES OF THREE HIV-1 HLA-B5703-PEPTIDE COMPLEXES AND IDENTIFICATION OF RELATED HLAS POTENTIALLY ASSOCIATED WITH LONG-TERM NON-PROGRESSION |
| 2BVQ | B: | STRUCTURES OF THREE HIV-1 HLA-B5703-PEPTIDE COMPLEXES AND IDENTIFICATION OF RELATED HLAS POTENTIALLY ASSOCIATED WITH LONG-TERM NON-PROGRESSION |
| 2C7U | B:; E: | CONFLICTING SELECTIVE FORCES AFFECT CD8 T-CELL RECEPTOR CONTACT SITES IN AN HLA-A2 IMMUNODOMINANT HIV EPITOPE. |
| 2CII | B: | THE CRYSTAL STRUCTURE OF H-2DB COMPLEXED WITH A PARTIAL PEPTIDE EPITOPE SUGGESTS AN MHC CLASS I ASSEMBLY-INTERMEDIATE |
| 2CIK | B: | INSIGHTS INTO CROSSREACTIVITY IN HUMAN ALLORECOGNITION: THE STRUCTURE OF HLA-B35011 PRESENTING AN EPITOPE DERIVED FROM CYTOCHROME P450. |
| 2CLR | B:; E: | THREE DIMENSIONAL STRUCTURE OF A PEPTIDE EXTENDING OUT ONE END OF A CLASS I MHC BINDING SITE |
| 2D31 | B:1-99; E:1-99 | CRYSTAL STRUCTURE OF DISULFIDE-LINKED HLA-G DIMER |
| 2D4F | A: | THE CRYSTAL STRUCTURE OF HUMAN BETA2-MICROGLOBULIN |
| 2DYP | B: | CRYSTAL STRUCTURE OF LILRB2(LIR2/ILT4/CD85D) COMPLEXED WITH HLA-G |
| 2ESV | B: | STRUCTURE OF THE HLA-E-VMAPRTLIL/KK50.4 TCR COMPLEX |
| 2F53 | B:1-99 | DIRECTED EVOLUTION OF HUMAN T-CELL RECEPTOR CDR2 RESIDUES BY PHAGE DISPLAY DRAMATICALLY ENHANCES AFFINITY FOR COGNATE PEPTIDE-MHC WITHOUT APPARENT CROSS-REACTIVITY |
| 2F54 | B:; G: | DIRECTED EVOLUTION OF HUMAN T CELL RECEPTOR CDR2 RESIDUES BY PHAGE DISPLAY DRAMATICALLY ENHANCES AFFINITY FOR COGNATE PEPTIDE-MHC WITHOUT INCREASING APPARENT CROSS-REACTIVITY |
| 2F74 | B:; E: | MURINE MHC CLASS I H-2DB IN COMPLEX WITH HUMAN B2-MICROGLOBULIN AND LCMV-DERIVED IMMUNODMINANT PEPTIDE GP33 |
| 2F8O | A:; B: | A NATIVE TO AMYLOIDOGENIC TRANSITION REGULATED BY A BACKBONE TRIGGER |
| 2FYY | B: | THE ROLE OF T CELL RECEPTOR ALPHA GENES IN DIRECTING HUMAN MHC RESTRICTION |
| 2FZ3 | B: | THE ROLE OF T CELL RECEPTOR ALPHA GENES IN DIRECTING HUMAN MHC RESTRICTION |
| 2GIT | B:; E: | HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE MODIFIED HTLV-1 TAX (Y5K-4-[3-INDOLYL]-BUTYRIC ACID) PEPTIDE |
| 2GJ6 | B: | THE COMPLEX BETWEEN TCR A6 AND HUMAN CLASS I MHC HLA-A2 WITH THE MODIFIED HTLV-1 TAX (Y5K-4-[3-INDOLYL]-BUTYRIC ACID) PEPTIDE |
| 2GT9 | B:; E: | HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE DECAMERIC MELAN-A/MART-1(26-35) PEPTIDE |
| 2GTW | B:; E: | HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE NONAMERIC MELAN-A/MART-1(27-35) PEPTIDE HAVING A27L SUBSTITUTION |
| 2GTZ | B:; E: | HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE NONAMERIC MELAN-A/MART-1(27-35) PEPTIDE HAVING A28L SUBSTITUTION |
| 2GUO | B:; E: | HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE NATIVE NONAMERIC MELAN-A/MART-1(27-35) PEPTIDE |
| 2H26 | B: | HUMAN CD1B IN COMPLEX WITH ENDOGENOUS PHOSPHATIDYLCHOLINE AND SPACER |
| 2H6P | B: | CRYSTAL STRUCTURE OF HLA-B*3501 PRESENTING THE HUMAN CYTOCHROME P450 DERIVED PEPTIDE, KPIVVLHGY |
| 2HJK | B: | CRYSTAL STRUCTURE OF HLA-B5703 AND HIV-1 PEPTIDE |
| 2HJL | B: | CRYSTAL STRUCTURE OF HLA-B5703 AND HIV-1 PEPTIDE |
| 2HLA | B: | SPECIFICITY POCKETS FOR THE SIDE CHAINS OF PEPTIDE ANTIGENS IN HLA-AW68 |
| 2HN7 | B: | HLA-A*1101 IN COMPLEX WITH HBV PEPTIDE HOMOLOGUE |
| 2J8U | B:; I: | LARGE CDR3A LOOP ALTERATION AS A FUNCTION OF MHC MUTATION. |
| 2JCC | B:; I: | AH3 RECOGNITION OF MUTANT HLA-A2 W167A |
| 2NW3 | B: | CRYSTAL STRUCTURE OF HLA-B*3508 PRESENTING EBV PEPTIDE EPLPQGQLTAY AT 1.7A |
| 2NX5 | B:; G:; L:; R: | CRYSTAL STRUCTURE OF ELS4 TCR BOUND TO HLA-B*3501 PRESENTING EBV PEPTIDE EPLPQGQLTAY AT 1.7A |
| 2P5E | B: | CRYSTAL STRUCTURES OF HIGH AFFINITY HUMAN T-CELL RECEPTORS BOUND TO PMHC REVEAL NATIVE DIAGONAL BINDING GEOMETRY |
| 2P5W | B: | CRYSTAL STRUCTURES OF HIGH AFFINITY HUMAN T-CELL RECEPTORS BOUND TO PMHC REVEAL NATIVE DIAGONAL BINDING GEOMETRY |
| 2PO6 | B:1-99; F:2-99 | CRYSTAL STRUCTURE OF CD1D-LIPID-ANTIGEN COMPLEXED WITH BETA-2-MICROGLOBULIN, NKT15 ALPHA-CHAIN AND NKT15 BETA-CHAIN |
| 2PYE | B: | CRYSTAL STRUCTURES OF HIGH AFFINITY HUMAN T-CELL RECEPTORS BOUND TO PMHC REVEALNATIVE DIAGONAL BINDING GEOMETRY TCR CLONE C5C1 COMPLEXED WITH MHC |
| 2RFX | B: | CRYSTAL STRUCTURE OF HLA-B*5701, PRESENTING THE SELF PEPTIDE, LSSPVTKSF |
| 2UWE | B:; I: | LARGE CDR3A LOOP ALTERATION AS A FUNCTION OF MHC MUTATION |
| 2V2W | B:; E: | T CELL CROSS-REACTIVITY AND CONFORMATIONAL CHANGES DURING TCR ENGAGEMENT |
| 2V2X | B:; E: | T CELL CROSS-REACTIVITY AND CONFORMATIONAL CHANGES DURING TCR ENGAGEMENT. |
| 2VB5 | A: | SOLUTION STRUCTURE OF W60G MUTANT OF HUMAN BETA2-MICROGLOBULIN |
| 2VLJ | B: | THE STRUCTURAL DYNAMICS AND ENERGETICS OF AN IMMUNODOMINANT T-CELL RECEPTOR ARE PROGRAMMED BY ITS VBETA DOMAIN |
| 2VLK | B: | THE STRUCTURAL DYNAMICS AND ENERGETICS OF AN IMMUNODOMINANT T-CELL RECEPTOR ARE PROGRAMMED BY ITS VBETA DOMAIN |
| 2VLL | B:; E: | THE STRUCTURAL DYNAMICS AND ENERGETICS OF AN IMMUNODOMINANT T-CELL RECEPTOR ARE PROGRAMMED BY ITS VBETA DOMAIN |
| 2VLR | B:; G: | THE STRUCTURAL DYNAMICS AND ENERGETICS OF AN IMMUNODOMINANT T-CELL RECEPTOR ARE PROGRAMMED BY ITS VBETA DOMAIN |
| 2X4N | B:; E: | CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2.1 BOUND TO RESIDUAL FRAGMENTS OF A PHOTOCLEAVABLE PEPTIDE THAT IS CLEAVED UPON UV-LIGHT TREATMENT |
| 2X4O | B:; E: | CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2.1 BOUND TO HIV-1 ENVELOPE PEPTIDE ENV120-128 |
| 2X4P | B:; E: | CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2.1 BOUND TO A PHOTOCLEAVABLE PEPTIDE |
| 2X4Q | B:; E: | CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2.1 BOUND TO A PHOTOCLEAVABLE PEPTIDE |
| 2X4R | B:; E: | CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2.1 BOUND TO CYTOMEGALOVIRUS (CMV) PP65 EPITOPE |
| 2X4S | B:; E: | CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2.1 BOUND TO A PEPTIDE REPRESENTING THE EPITOPE OF THE H5N1 (AVIAN FLU) NUCLEOPROTEIN |
| 2X4T | B:; E: | CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2.1 BOUND TO A PEIODATE-CLEAVABLE PEPTIDE |
| 2X4U | B:; E: | CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2.1 BOUND TO HIV-1 PEPTIDE RT468-476 |
| 2X70 | B:; E: | CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2.1 BOUND TO A PHOTOCLEAVABLE PEPTIDE |
| 2XKS | A: | PRION-LIKE CONVERSION DURING AMYLOID FORMATION AT ATOMIC RESOLUTION |
| 2YXF | A: | THE HIGH RESOLUTION CRYSTAL STRUCTURE OF BETA2-MICROGLOBULIN UNDER PHYSIOLOGICAL CONDITIONS |
| 2Z9T | A: | CRYSTAL STRUCTURE OF THE HUMAN BETA-2 MICROGLOBULIN MUTANT W60G |
| 3B3I | B: | CITRULLINATION-DEPENDENT DIFFERENTIAL PRESENTATION OF A SELF-PEPTIDE BY HLA-B27 SUBTYPES |
| 3B6S | B: | CRYSTAL STRUCTURE OF HLA-B*2705 COMPLEXED WITH THE CITRULLINATED VASOACTIVE INTESTINAL PEPTIDE TYPE 1 RECEPTOR (VIPR) PEPTIDE (RESIDUES 400-408) |
| 3BGM | B: | CRYSTAL STRUCTURE OF PKD2 PHOSPHOPEPTIDE BOUND TO HUMAN CLASS I MHC HLA-A2 |
| 3BH8 | B: | CRYSTAL STRUCTURE OF RQA_M PHOSPHOPEPTIDE BOUND TO HUMAN CLASS I MHC HLA-A2 |
| 3BH9 | B: | CRYSTAL STRUCTURE OF RTY PHOSPHOPEPTIDE BOUND TO HUMAN CLASS I MHC HLA-A2 |
| 3BHB | B: | CRYSTAL STRUCTURE OF KMD PHOSPHOPEPTIDE BOUND TO HUMAN CLASS I MHC HLA-A2 |
| 3BO8 | B: | THE HIGH RESOLUTION CRYSTAL STRUCTURE OF HLA-A1 COMPLEXED WITH THE MAGE-A1 PEPTIDE |
| 3BP4 | B: | THE HIGH RESOLUTION CRYSTAL STRUCTURE OF HLA-B*2705 IN COMPLEX WITH A CATHEPSIN A SIGNAL SEQUENCE PEPTIDE PCATA |
| 3BP7 | B: | THE HIGH RESOLUTION CRYSTAL STRUCTURE OF HLA-B*2709 IN COMPLEX WITH A CATHEPSIN A SIGNAL SEQUENCE PEPTIDE, PCATA |
| 3BVN | B:; E: | HIGH RESOLUTION CRYSTAL STRUCTURE OF HLA-B*1402 IN COMPLEX WITH THE LATENT MEMBRANE PROTEIN 2 PEPTIDE (LMP2) OF EPSTEIN-BARR VIRUS |
| 3BW9 | B: | CRYSTAL STRUCTURE OF HLA B*3508 IN COMPLEX WITH A HCMV 12-MER PEPTIDE FROM THE PP65 PROTEIN |
| 3BWA | B: | CRYSTAL STRUCTURE OF HLA B*3508 IN COMPLEX WITH A HCMV 8-MER PEPTIDE FROM THE PP65 PROTEIN |
| 3BXN | B: | THE HIGH RESOLUTION CRYSTAL STRUCTURE OF HLA-B*1402 COMPLEXED WITH A CATHEPSIN A SIGNAL SEQUENCE PEPTIDE, PCATA |
| 3BZE | B:; D:; F:; H: | THE HUMAN NON-CLASSICAL MAJOR HISTOCOMPATIBILITY COMPLEX MOLECULE HLA-E |
| 3C9N | B: | CRYSTAL STRUCTURE OF A SARS CORONA VIRUS DERIVED PEPTIDE BOUND TO THE HUMAN MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I MOLECULE HLA-B*1501 |
| 3CDG | B:0-99; D:0-99 | HUMAN CD94/NKG2A IN COMPLEX WITH HLA-E |
| 3CII | B:0-99; E:0-99 | STRUCTURE OF NKG2A/CD94 BOUND TO HLA-E |
| 3CIQ | A:; B:; C:; D:; E:; F:; G:; H:; I:; J:; K:; L: | A REGULATABLE SWITCH MEDIATES SELF-ASSOCIATION IN AN IMMUNOGLOBULIN FOLD |
| 3CZF | B: | CRYSTAL STRUCTURE OF HLA-B*2709 COMPLEXED WITH THE GLUCAGON RECEPTOR (GR) PEPTIDE (RESIDUES 412-420) |
| 3D18 | B: | CRYSTAL STRUCTURE OF HLA-B*2709 COMPLEXED WITH A VARIANT OF THE LATENT MEMBRANE PROTEIN 2 PEPTIDE (LMP2(L)) OF EPSTEIN-BARR VIRUS |
| 3D25 | B: | CRYSTAL STRUCTURE OF HA-1 MINOR HISTOCOMPATIBILITY ANTIGEN BOUND TO HUMAN CLASS I MHC HLA-A2 |
| 3D2U | B:; F: | STRUCTURE OF UL18, A PEPTIDE-BINDING VIRAL MHC MIMIC, BOUND TO A HOST INHIBITORY RECEPTOR |
| 3D39 | B: | THE COMPLEX BETWEEN TCR A6 AND HUMAN CLASS I MHC HLA-A2 WITH THE MODIFIED HTLV-1 TAX (Y5(4-FLUOROPHENYLALANINE)) PEPTIDE |
| 3D3V | B: | THE COMPLEX BETWEEN TCR A6 AND HUMAN CLASS I MHC HLA-A2 WITH THE MODIFIED HTLV-1 TAX (Y5(3,4-DIFLUOROPHENYLALANINE)) PEPTIDE |
| 3DBX | B: | STRUCTURE OF CHICKEN CD1-2 WITH BOUND FATTY ACID |
| 3DHJ | A: | BETA 2 MICROGLOBULIN MUTANT W60C |
| 3DHM | A: | BETA 2 MICROGLOBULIN MUTANT D59P |
| 3DTX | B: | CRYSTAL STRUCTURE OF HLA-B*2705 COMPLEXED WITH THE DOUBLE CITRULLINATED VASOACTIVE INTESTINAL PEPTIDE TYPE 1 RECEPTOR (VIPR) PEPTIDE (RESIDUES 400-408) |
| 3DX6 | B: | CRYSTAL STRUCTURE OF B*4402 PRESENTING A 10MER EBV EPITOPE |
| 3DX7 | B: | CRYSTAL STRUCTURE OF HLA-B*4403 PRESENTING 10MER EBV ANTIGEN |
| 3DX8 | B: | CRYSTAL STRUCTURE OF B*4405 PRESENTING A 10MER EBV EPITOPE |
| 3EKC | A: | STRUCTURE OF W60V BETA-2 MICROGLOBULIN MUTANT |
| 3FFC | B:; G: | CRYSTAL STRUCTURE OF CF34 TCR IN COMPLEX WITH HLA-B8/FLR |
| 3FQN | B: | PHOSPHORYLATION OF SELF-PEPTIDES ALTERS HUMAN LEUKOCYTE ANTIGEN CLASS I-RESTRICTED ANTIGEN PRESENTATION AND GENERATES TUMOR SPECIFIC EPITOPES |
| 3FQR | B: | PHOSPHORYLATION OF SELF-PEPTIDES ALTERS HUMAN LEUKOCYTE ANTIGEN CLASS I-RESTRICTED ANTIGEN PRESENTATION AND GENERATES TUMOR SPECIFIC EPITOPES |
| 3FQT | B: | PHOSPHORYLATION OF SELF-PEPTIDES ALTERS HUMAN LEUKOCYTE ANTIGEN CLASS I-RESTRICTED ANTIGEN PRESENTATION AND GENERATES TUMOR SPECIFIC EPITOPES |
| 3FQU | B: | PHOSPHORYLATION OF SELF-PEPTIDES ALTERS HUMAN LEUKOCYTE ANTIGEN CLASS I-RESTRICTED ANTIGEN PRESENTATION AND GENERATES TUMOR SPECIFIC EPITOPES |
| 3FQW | B: | PHOSPHORYLATION OF SELF-PEPTIDES ALTERS HUMAN LEUKOCYTE ANTIGEN CLASS I-RESTRICTED ANTIGEN PRESENTATION AND GENERATES TUMOR SPECIFIC EPITOPES |
| 3FQX | B: | PHOSPHORYLATION OF SELF-PEPTIDES ALTERS HUMAN LEUKOCYTE ANTIGEN CLASS I-RESTRICTED ANTIGEN PRESENTATION AND GENERATES TUMOR SPECIFIC EPITOPES |
| 3FT2 | B: | CRYSTAL STRUCTURE OF A CITRULLINE PEPTIDE VARIANT OF THE MINOR HISTOCOMPATIBILITY PEPTIDE HA-1 IN COMPLEX WITH HLA-A2 |
| 3FT3 | B: | CRYSTAL STRUCTURE OF THE MINOR HISTOCOMPATIBILITY PEPTIDE HA-1HIS IN COMPLEX WITH HLA-A2 |
| 3FT4 | B: | CRYSTAL STRUCTURE OF THE MINOR HISTOCOMPATIBILITY PEPTIDE HA-1ARG IN COMPLEX WITH HLA-A2 |
| 3GIV | B:; E: | ANTIGEN PROCESSING INFLUENCES HIV-SPECIFIC CYTOTOXIC T LYMPHOCYTE IMMUNODOMINANCE |
| 3GJF | B:; E: | RATIONAL DEVELOPMENT OF HIGH-AFFINITY T-CELL RECEPTOR-LIKE ANTIBODIES |
| 3GSN | L: | CRYSTAL STRUCTURE OF THE PUBLIC RA14 TCR IN COMPLEX WITH THE HCMV DOMINANT NLV/HLA-A2 EPITOPE |
| 3GSO | B: | CRYSTAL STRUCTURE OF THE BINARY COMPLEX BETWEEN HLA-A2 AND HCMV NLV PEPTIDE |
| 3GSQ | B: | CRYSTAL STRUCTURE OF THE BINARY COMPLEX BETWEEN HLA-A2 AND HCMV NLV-M5S PEPTIDE VARIANT |
| 3GSR | B: | CRYSTAL STRUCTURE OF THE BINARY COMPLEX BETWEEN HLA-A2 AND HCMV NLV-M5V PEPTIDE VARIANT |
| 3GSU | B: | CRYSTAL STRUCTURE OF THE BINARY COMPLEX BETWEEN HLA-A2 AND HCMV NLV-M5T PEPTIDE VARIANT |
| 3GSV | B: | CRYSTAL STRUCTURE OF THE BINARY COMPLEX BETWEEN HLA-A2 AND HCMV NLV-M5Q PEPTIDE VARIANT |
| 3GSW | B: | CRYSTAL STRUCTURE OF THE BINARY COMPLEX BETWEEN HLA-A2 AND HCMV NLV-T8A PEPTIDE VARIANT |
| 3GSX | B: | CRYSTAL STRUCTURE OF THE BINARY COMPLEX BETWEEN HLA-A2 AND HCMV NLV-T8V PEPTIDE VARIANT |
| 3H7B | B:; E: | HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE TEL1P PEPTIDE |
| 3H9H | B:; E: | HUMAN CLASS I MHC HLA-A2(A150P) IN COMPLEX WITH THE TEL1P PEPTIDE |
| 3H9S | B: | THE COMPLEX BETWEEN TCR A6 AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND TEL1P PEPTIDE |
| 3HAE | B:; E:; K:; Q: | RATIONAL DEVELOPMENT OF HIGH-AFFINITY T-CELL RECEPTOR-LIKE ANTIBODIES |
| 3HCV | B: | CRYSTAL STRUCTURE OF HLA-B*2709 COMPLEXED WITH THE DOUBLE CITRULLINATED VASOACTIVE INTESTINAL PEPTIDE TYPE 1 RECEPTOR (VIPR) PEPTIDE (RESIDUES 400-408) |
| 3HLA | B: | HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN A2.1 |
| 3HPJ | B:; E: | HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE WT-1 (126-134) PEPTIDE |
| 3HUJ | B:; D: | CRYSTAL STRUCTURE OF HUMAN CD1D-ALPHA-GALACTOSYLCERAMIDE IN COMPLEX WITH SEMI-INVARIANT NKT CELL RECEPTOR |
| 3I6G | B:; E: | NEWLY IDENTIFIED EPITOPE MN2 FROM SARS-COV M PROTEIN COMPLEXED WITHHLA-A*0201 |
| 3I6K | B:; F: | NEWLY IDENTIFIED EPITOPE FROM SARS-COV MEMBRANE PROTEIN COMPLEXED WITH HLA-A*0201 |
| 3I6L | E: | NEWLY IDENTIFIED EPITOPE N1 DERIVED FROM SARS-COV N PROTEIN COMPLEXED WITH HLA-A*2402 |
| 3IB4 | A: | THE DOUBLE MUTANT OF BETA-2 MICROGLOBULIN K58P-W60G |
| 3IXA | B:; E: | HUMAN CLASS I MHC HLA-A2(A150P) IN COMPLEX WITH THE TAX PEPTIDE |
| 3JTT | H: | CYSTAL STRUCTURE OF RHESUS MACAQUE MHC CLASS I:MAMU-A*02 |
| 3KLA | B:; E: | CA2+ RELEASE FROM THE ENDOPLASMIC RETICULUM OF NY-ESO-1 SPECIFIC T CELLS IS MODULATED BY THE AFFINITY OF T CELL RECEPTOR AND BY THE USE OF THE CD8 CO-RECEPTOR |
| 3KPL | B: | CRYSTAL STRUCTURE OF HLA B*4402 IN COMPLEX WITH EEYLQAFTY A SELF PEPTIDE FROM THE ABCD3 PROTEIN |
| 3KPM | B: | CRYSTAL STRUCTURE OF HLA B*4402 IN COMPLEX WITH EEYLKAWTF, A MIMOTOPE |
| 3KPN | B: | CRYSTAL STRUCTURE OF HLA B*4403 IN COMPLEX WITH EEYLQAFTY A SELF PEPTIDE FROM THE ABCD3 PROTEIN |
| 3KPO | B: | CRYSTAL STRUCTURE OF HLA B*4403 IN COMPLEX WITH EEYLKAWTF, A MIMOTOPE |
| 3KPP | B: | CRYSTAL STRUCTURE OF HLA B*4405 IN COMPLEX WITH EEYLQAFTY A SELF PEPTIDE FROM THE ABCD3 PROTEIN |
| 3KPQ | B: | CRYSTAL STRUCTURE OF HLA B*4405 IN COMPLEX WITH EEYLKAWTF, A MIMOTOPE |
| 3KPR | B:; G: | CRYSTAL STRUCTURE OF THE LC13 TCR IN COMPLEX WITH HLA B*4405 BOUND TO EEYLKAWTF A MIMOTOPE |
| 3KPS | B: | CRYSTAL STRUCTURE OF THE LC13 TCR IN COMPLEX WITH HLA B*4405 BOUND TO EEYLQAFTY A SELF PEPTIDE FROM THE ABCD3 PROTEIN |
| 3KWW | B: | CRYSTAL STRUCTURE OF THE 'RESTRICTION TRIAD' MUTANT OF HLA B*3508, BETA-2-MICROGLOBULIN AND EBV PEPTIDE |
| 3KYN | B: | CRYSTAL STRUCTURE OF HLA-G PRESENTING KGPPAALTL PEPTIDE |
| 3KYO | B:; D: | CRYSTAL STRUCTURE OF HLA-G PRESENTING KLPAQFYIL PEPTIDE |
| 3L3D | B: | CRYSTAL STRUCTURE OF HLA-B*4402 IN COMPLEX WITH THE F3A MUTANT OF A SELF-PEPTIDE DERIVED FROM DPA*0201 |
| 3L3G | B: | CRYSTAL STRUCTURE OF HLA-B*4402 IN COMPLEX WITH THE R5A MUTANT OF A SELF-PEPTIDE DERIVED FROM DPA*0201 |
| 3L3I | B: | CRYSTAL STRUCTURE OF HLA-B*4402 IN COMPLEX WITH THE F7A MUTANT OF A SELF-PEPTIDE DERIVED FROM DPA*0201 |
| 3L3J | B: | CRYSTAL STRUCTURE OF HLA-B*4402 IN COMPLEX WITH THE F3A/R5A DOUBLE MUTANT OF A SELF-PEPTIDE DERIVED FROM DPA*0201 |
| 3L3K | B: | CRYSTAL STRUCTURE OF HLA-B*4402 IN COMPLEX WITH THE R5A/F7A DOUBLE MUTANT OF A SELF-PEPTIDE DERIVED FROM DPA*0201 |
| 3LKN | B: | CRYSTAL STRUCTURE OF HLA B*3501 IN COMPLEX WITH INFLUENZA NP418 EPITOPE FROM 1918 STRAIN |
| 3LKO | B: | CRYSTAL STRUCTURE OF HLA B*3501 IN COMPLEX WITH INFLUENZA NP418 EPITOPE FROM 1934 STRAIN |
| 3LKP | B: | CRYSTAL STRUCTURE OF HLA B*3501 IN COMPLEX WITH INFLUENZA NP418 EPITOPE FROM 1972 STRAIN |
| 3LKQ | B: | CRYSTAL STRUCTURE OF HLA B*3501 IN COMPLEX WITH INFLUENZA NP418 EPITOPE FROM 1977 STRAIN |
| 3LKR | B: | CRYSTAL STRUCTURE OF HLA B*3501 IN COMPLEX WITH INFLUENZA NP418 EPITOPE FROM 2009 H1N1 SWINE ORIGIN STRAIN |
| 3LKS | B: | CRYSTAL STRUCTURE OF HLA B*3501 IN COMPLEX WITH INFLUENZA NP418 EPITOPE FROM 1980 STRAIN |
| 3LN4 | B: | CRYSTAL STRUCTURE OF HLA-B*4103 IN COMPLEX WITH A 16MER SELF-PEPTIDE DERIVED FROM HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEINS C1/C2 |
| 3LN5 | B: | CRYSTAL STRUCTURE OF HLA-B*4104 IN COMPLEX WITH A 11MER SELF-PEPTIDE DERIVED FROM S-METHYL-5-THIOADENOSINE PHOSPHORYLASE |
| 3LOW | A:; B: | CRYSTAL STRUCTURE OF BETA 2 MICROGLOBULIN DOMAIN-SWAPPED DIMER |
| 3LV3 | B: | CRYSTAL STRUCTURE OF HLA-B*2705 COMPLEXED WITH A PEPTIDE DERIVED FROM THE HUMAN VOLTAGE-DEPENDENT CALCIUM CHANNEL ALPHA1 SUBUNIT (RESIDUES 513-521) |
| 3M17 | B:; D:; F:; H: | CRYSTAL STRUCTURE OF HUMAN FCRN WITH A MONOMERIC PEPTIDE INHIBITOR |
| 3M1B | B:; D:; F:; H: | CRYSTAL STRUCTURE OF HUMAN FCRN WITH A DIMERIC PEPTIDE INHIBITOR |
| 3MGO | B:; E:; H:; K: | CRYSTAL STRUCTURE OF A H5-SPECIFIC CTL EPITOPE DERIVED FROM H5N1 INFLUENZA VIRUS IN COMPLEX WITH HLA-A*0201 |
| 3MGT | B:; E:; H:; K: | CRYSTAL STRUCTURE OF A H5-SPECIFIC CTL EPITOPE VARIANT DERIVED FROM H5N1 INFLUENZA VIRUS IN COMPLEX WITH HLA-A*0201 |
| 3MR9 | B: | CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH HCMV PP65-495-503 NONAPEPTIDE M5A VARIANT |
| 3MRB | B: | CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH HCMV PP65-495-503 NONAPEPTIDE A7H VARIANT |
| 3MRC | B: | CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH HCMV PP65-495-503 NONAPEPTIDE V6C VARIANT |
| 3MRD | B: | CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH HCMV PP65-495-503 NONAPEPTIDE V6G VARIANT |
| 3MRE | B: | CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH EBV BMLF1-280-288 NONAPEPTIDE |
| 3MRF | B: | CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH EBV BMLF1-280-288 NONAPEPTIDE T4P VARIANT |
| 3MRG | B: | CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH HCV NS3-1073-1081 NONAPEPTIDE |
| 3MRH | B: | CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH HCV NS3-1073-1081 NONAPEPTIDE N3S VARIANT |
| 3MRI | B: | CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH HCV NS3-1073-1081 NONAPEPTIDE G4M-V5W VARIANT |
| 3MRJ | B: | CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH HCV NS3-1073-1081 NONAPEPTIDE V5M VARIANT |
| 3MRK | B: | CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH AFP137 NONAPEPTIDE |
| 3MRL | B: | CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH HCV NS3-1073-1081 NONAPEPTIDE C6V VARIANT |
| 3MRM | B: | CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH HCV NS3-1406-1415 DECAPEPTIDE |
| 3MRN | B: | CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH HCV NS4B-1807-1816 DECAPEPTIDE |
| 3MRO | B: | CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH MELAN-A MART1 DECAPEPTIDE VARIANT |
| 3MRP | B: | CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH MELAN-A MART1 DECAPEPTIDE VARIANT |
| 3MRQ | B: | CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH MELAN-A MART1 DECAPEPTIDE VARIANT |
| 3MRR | B: | CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH HUMAN PROSTAGLANDIN TRANSPORTER DECAPEPTIDE |
| 3MV7 | B: | CRYSTAL STRUCTURE OF THE TK3 TCR IN COMPLEX WITH HLA-B*3501/HPVG |
| 3MV8 | B: | CRYSTAL STRUCTURE OF THE TK3-GLN55HIS TCR IN COMPLEX WITH HLA-B*3501/HPVG |
| 3MV9 | B: | CRYSTAL STRUCTURE OF THE TK3-GLN55ALA TCR IN COMPLEX WITH HLA-B*3501/HPVG |
| 3MYJ | B:; E: | HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE WT-1 (126-134) (R1Y) PEPTIDE VARIANT. |
| 3MYZ | A:; B: | PROTEIN INDUCED PHOTOPHYSICAL CHANGES TO THE AMYLOID INDICATOR DYE, THIOFLAVIN T |
| 3MZT | A:; B:; C:; D:; E:; F: | PROTEIN-INDUCED PHOTOPHYSICAL CHANGES TO THE AMYLOID INDICATOR DYE, THIOFLAVIN T |
| 3NA4 | A: | D53P BETA-2 MICROGLOBULIN MUTANT |
| 3O3A | B:; E: | HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE PEPTIDOMIMETIC ELA-1 |
| 3O3B | B:; E: | HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE PEPTIDOMIMETIC ELA-1.1 |
| 3O3D | B:; E: | HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE PEPTIDOMIMETIC ELA-2 |
| 3O3E | B:; E: | HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE PEPTIDOMIMETIC ELA-2.1 |
| 3O4L | B: | GENETIC AND STRUCTURAL BASIS FOR SELECTION OF A UBIQUITOUS T CELL RECEPTOR DEPLOYED IN EPSTEIN-BARR VIRUS |
| 3OX8 | B:; E: | CRYSTAL STRUCTURE OF HLA A*02:03 BOUND TO HBV CORE 18-27 |
| 3OXR | B: | CRYSTAL STRUCTURE OF HLA A*02:06 BOUND TO HBV CORE 18-27 |
| 3OXS | B: | CRYSTAL STRUCTURE OF HLA A*02:07 BOUND TO HBV CORE 18-27 |
| 3PWJ | B:; E: | HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE HUD (G2L,I9V) PEPTIDE VARIANT |
| 3PWL | B:; E: | HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE HUD PEPTIDE |
| 3PWN | B:; E: | HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE HUD (G2L) PEPTIDE VARIANT |
| 3PWP | B: | THE COMPLEX BETWEEN TCR A6 AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND HUD PEPTIDE |
| 3QDA | A: | CRYSTAL STRUCTURE OF W95L BETA-2 MICROGLOBULIN |
| 3QDG | B: | THE COMPLEX BETWEEN TCR DMF5 AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND MART-1(26-35)(A27L) PEPTIDE |
| 3QDJ | B: | THE COMPLEX BETWEEN TCR DMF5 AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND MART-1(27-35) NONAMERIC PEPTIDE |
| 3QDM | B: | THE COMPLEX BETWEEN TCR DMF4 AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND MART-1(26-35)(A27L) DECAMERIC PEPTIDE |
| 3QEQ | B: | THE COMPLEX BETWEEN TCR DMF4 AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND MART-1(27-35) NONAMERIC PEPTIDE |
| 3QFD | B:; E: | HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH MART-1(27-35) NONAMERIC PEPTIDE |
| 3QFJ | B: | THE COMPLEX BETWEEN TCR A6 AND HUMAN CLASS I MHC HLA-A2 WITH THE MODIFIED TAX (Y5F) PEPTIDE |
| 3QZW | B:; E: | PLASTICITY OF HUMAN CD8 BINDING TO PEPTIDE-HLA-A*2402 |
| 3REW | B:; E: | CRYSTAL STRUCTURE OF AN LMP2A-DERIVED PEPTIDE BOUND TO HUMAN CLASS I MHC HLA-A2 |
| 3SDX | B:; D: | CRYSTAL STRUCTURE OF HUMAN AUTOREACTIVE-VALPHA24 NKT TCR IN COMPLEX WITH CD1D-BETA-GALACTOSYLCERAMIDE |
| 3T8X | B:; D: | CRYSTAL STRUCTURE OF HUMAN CD1B IN COMPLEX WITH SYNTHETIC ANTIGENIC DIACYLSULFOGLYCOLIPID SGL12 AND ENDOGENOUS SPACER |
| 3TLR | A:; B:; C:; D: | CRYSTAL STRUCTURE OF THE TETRAMERIC BETA-2 MICROGLOBULIN DIMC20 MUTANT |
| 3TM6 | A:; B:; C:; D:; E:; F:; G:; H: | CRYSTAL STRUCTURE OF THE BETA-2 MICROGLOBULIN DIMC50 DISULPHIDE-LINKED HOMODIMER MUTANT |
| 3TZV | D: | CRYSTAL STRUCTURE OF AN INKT TCR IN COMPLEX WITH CD1D-LYSOPHOSPHATIDYLCHOLINE |
| 3U0P | B:; D:; F: | CRYSTAL STRUCTURE OF HUMAN CD1D-LYSOPHOSPHATIDYLCHOLINE |
| 3UPR | B:; D: | HLA-B*57:01 COMPLEXED TO PEP-V AND ABACAVIR |
| 3UTQ | B: | HUMAN HLA-A*0201-ALWGPDPAAA |
| 3UTS | B:; G: | 1E6-A*0201-ALWGPDPAAA COMPLEX, MONOCLINIC |
| 3UTT | B:; G: | 1E6-A*0201-ALWGPDPAAA COMPLEX, TRICLINIC |
| 3VH8 | B:; E: | KIR3DL1 IN COMPLEX WITH HLA-B*5701 |
| 3VWJ | B: | TERNARY CRYSTAL STRUCTURE OF THE HUMAN NKT TCR-CD1D-C20:2 COMPLEX |
| 3VWK | B: | TERNARY CRYSTAL STRUCTURE OF THE HUMAN NKT TCR-CD1D-4'DEOXY-ALPHA-GALACTOSYLCERAMIDE COMPLEX |
| 4EN3 | B:118-242; D: | CRYSTAL STRUCTURE OF A HUMAN VALPHA24(-) NKT TCR IN COMPLEX WITH CD1D/ALPHA-GALACTOSYLCERAMIDE |
| 4FXL | A: | CRYSTAL STRUCTURE OF THE D76N BETA-2 MICROGLOBULIN MUTANT |
| 4K71 | C:; F: | CRYSTAL STRUCTURE OF A HIGH AFFINITY HUMAN SERUM ALBUMIN VARIANT BOUND TO THE NEONATAL FC RECEPTOR |
| 4KDT | C:; D: | STRUCTURE OF AN EARLY NATIVE-LIKE INTERMEDIATE OF BETA2-MICROGLOBULIN AMYLOIDOSIS |
| 4L29 | B:; D:; F:; H:; J:; L:; N:; P:; R:; T:; V:; X:; Z: | STRUCTURE OF WTMHC CLASS I WITH NY-ESO1 DOUBLE MUTANT |
| 4L3C | B:; D:; F:; H:; J:; L:; N:; P:; R:; T:; V:; X:; Z: | STRUCTURE OF HLA-A2 IN COMPLEX WITH D76N B2M MUTANT AND NY-ESO1 DOUBLE MUTANT |
| 4L4T | B:; F: | STRUCTURE OF HUMAN MAIT TCR IN COMPLEX WITH HUMAN MR1-6-FP |
| 4L4V | B:; F: | STRUCTURE OF HUMAN MAIT TCR IN COMPLEX WITH HUMAN MR1-RL-6-ME-7-OH |
| 4LCW | B:; F: | THE STRUCTURE OF HUMAN MAIT TCR IN COMPLEX WITH MR1-K43A-RL-6-ME-7OH |
| 4LHU | B: | CRYSTAL STRUCTURE OF 9C2 TCR BOUND TO CD1D |
| 4N0F | B:; F:; I:; L: | HUMAN FCRN COMPLEXED WITH HUMAN SERUM ALBUMIN |
)
)